Toshiyuki Sakaki Selected Research

Vitamin D3 24-Hydroxylase

4/2022	Novel DNA Aptamer for CYP24A1 Inhibition with Enhanced Antiproliferative Activity in Cancer Cells.
1/2021	Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 system.
1/2014	CYP24A1 as a potential target for cancer therapy.
4/2013	1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.
1/2012	The roles of cytochrome P450 enzymes in prostate cancer development and treatment.
11/2011	Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
9/2009	Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
5/2009	The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiyuki Sakaki Research Topics

Disease

14	Neoplasms (Cancer) 04/2022 - 10/2003
12	Osteoporosis 04/2022 - 06/2005
7	Rickets (Rachitis) 10/2021 - 05/2004
5	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 09/2007
5	Leukemia 01/2019 - 10/2003
5	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 04/2004
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 10/2003
2	Chronic Renal Insufficiency 04/2022 - 01/2019
2	Rheumatoid Arthritis 01/2019 - 05/2011
2	Hypocalcemia 01/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 10/2015 - 05/2009
2	Hypercalcemia (Milk Alkali Syndrome) 04/2013 - 10/2012
2	Colonic Neoplasms (Colon Cancer) 05/2004 - 04/2004
2	Hepatoblastoma 05/2004 - 04/2004
1	Body Weight (Weight, Body) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Multiple Sclerosis 01/2019
1	Postmenopausal Osteoporosis 01/2018
1	Bone Resorption 01/2018
1	Hypertrophy 01/2018
1	Cognitive Dysfunction 01/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Hyperglycemia 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 01/2017
1	Alopecia (Baldness) 01/2017
1	Mobility Limitation (Difficulty Walking) 01/2017
1	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2017
1	Hypophosphatemic Rickets 01/2017
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 10/2015
1	Smith-Lemli-Opitz Syndrome 03/2014
1	Nephrocalcinosis 04/2013
1	Nephrolithiasis 04/2013
1	Undiagnosed Diseases 04/2013
1	Hypercalciuria 04/2013
1	Liver Neoplasms (Liver Cancer) 10/2012
1	Muscular Diseases (Myopathy) 10/2010
1	Intestinal Neoplasms (Intestinal Cancer) 08/2009

Drug/Important Bio-Agent (IBA)

18	Vitamin D FDA LinkGeneric 10/2021 - 05/2004
17	hydroxide ionIBA 01/2021 - 04/2004
8	Vitamin D3 24-HydroxylaseIBA 04/2022 - 05/2009
8	LigandsIBA 12/2021 - 01/2006
8	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2018 - 05/2009
6	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2018 - 05/2004
5	Cholecalciferol (Vitamin D3)FDA Link 11/2016 - 01/2005
4	OsteocalcinIBA 01/2018 - 09/2009
4	Pharmaceutical PreparationsIBA 03/2015 - 01/2005
3	EnzymesIBA 04/2022 - 01/2012
3	AndrogensIBA 12/2021 - 09/2009
3	Calcitriol (Calcijex)FDA LinkGeneric 01/2020 - 05/2009
3	Therapeutic UsesIBA 01/2018 - 11/2016
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2012 - 06/2005
3	Calcifediol (Calcidiol)FDA Link 08/2005 - 05/2004
2	paricalcitol (Zemplar)FDA Link 01/2019 - 09/2009
2	CalciumIBA 01/2018 - 06/2005
2	eldecalcitol (ED 71)IBA 01/2018 - 03/2015
2	Parathyroid Hormone (Parathormone)IBA 01/2018 - 04/2013
2	LuciferasesIBA 10/2015 - 09/2009
2	Vitamin D-Binding ProteinIBA 01/2013 - 09/2009
2	Biological ProductsIBA 10/2012 - 09/2009
2	19- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3IBA 11/2011 - 09/2009
2	1,25-dihydroxyvitamin DIBA 01/2006 - 10/2003
1	Cytochrome P450 Family 24IBA 04/2022
1	VitaminsIBA 04/2022
1	Nucleotide AptamersIBA 04/2022
1	Androgen Receptors (Androgen Receptor)IBA 12/2021
1	1,25-dihydroxyergocalciferolIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2019
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 01/2019
1	iguratimodIBA 01/2019
1	Dimethyl FumarateIBA 01/2019
1	MineralsIBA 01/2018
1	alfacalcidolIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2017
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	daidzeinIBA 01/2017
1	EquolIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 03/2015
1	SterolsIBA 03/2015
1	7-dehydrocholesterolIBA 03/2014
1	Mixed Function Oxygenases (Monooxygenases)IBA 04/2013
1	calcium phosphateIBA 04/2013
1	CarbonIBA 11/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2011
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2011
1	propionic acid (potassium propionate)IBA 05/2011
1	Fluvastatin FDA Link 10/2010
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2009
1	Tryptophan (L-Tryptophan)FDA Link 08/2009
1	XenobioticsIBA 08/2009
1	GlucosinolatesIBA 08/2009
1	indoleIBA 08/2009
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 08/2009

Therapy/Procedure

5	Therapeutics 01/2014 - 09/2007
1	Chemoprevention 08/2009